I can confirm EDE placement had an extremely strong demand. I was only able to get 40 % of my bid amount, which is highly unusual being a big size raise.
I am in as I sincerely think Eden Innovations is at the inflection point and the hard work from the team about to give them some solid traction going forward
Five products: EdenCrete®, EdenCrete Pz®, OptiBlend®, EdenPlast®, Hydrogen
Strong year on year revenue growth anticipated for FY21 and beyond.
Proprietary technology and core expertise in manufacturing and production of carbon nanotubes, hydrogen and carbon nanotube enriched products.
Core product EdenCrete® operates in global concrete market expected to reach US $921 billion and growing at approx. 8% p.a.
High barriers to market entry, with over 10 years in product development, established direct working relationships with Government departments, plus strong patent protection and proprietary technology.
Significant US Government traction with product approval from 20 Departments of Transportation.
Strong EdenCrete sales growth emerging: Sales in 11 US states, trials in 15 US states, first major contract (for EMP protection in US) worth up to US$48 million over 8 years
Emerging sales in India, Australia, Israel.
OptiBlend -Sales growing in US, India and Africa; Many markets applications; Major expansion of Indian sales anticipated in greater Delhi where due to extreme air pollution, proposed government banned use of diesel-only gensets during winter.
EdenPlast -First trial with CNT enriched masterbatch underway in Japan
Significantly growing momentum -anticipated to result in strong news flow pipeline
Should do very well as it was trading cum raise for a while
Easy Hold IMO
- Forums
- ASX - By Stock
- EDE
- Ann: Trading Halt
Ann: Trading Halt, page-137
-
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EDE (ASX) to my watchlist
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.427M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 204793284 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 10206803 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
66 | 204793284 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 10206803 | 10 |
0.003 | 51095595 | 28 |
0.004 | 8849367 | 7 |
0.005 | 360000 | 1 |
0.006 | 2831956 | 1 |
Last trade - 16.12pm 15/07/2024 (20 minute delay) ? |
Featured News
EDE (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online